Rothschild Capital Partners, LLC Merck & Co., Inc. Transaction History
Rothschild Capital Partners, LLC
- $406 Million
- Q4 2024
A detailed history of Rothschild Capital Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rothschild Capital Partners, LLC holds 62,026 shares of MRK stock, worth $5.72 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
62,026
Previous 61,961
0.1%
Holding current value
$5.72 Million
Previous $7.04 Million
12.31%
% of portfolio
1.52%
Previous 1.97%
Shares
11 transactions
Others Institutions Holding MRK
# of Institutions
3,965Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.2 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.2 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.45 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.64 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $234B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...